Tirzepatide
Description
A dual GIP and GLP-1 receptor agonist activating two incretin pathways at once, with pronounced research effects on appetite, blood sugar and body weight (up to ~22.5% reduction in trials).
- Dual GIP + GLP-1 agonist
- Studied for appetite signalling & gastric emptying
- Studied for insulin sensitivity
- Long-acting weekly profile
For laboratory and research use only. Supplied in sterile, flip-top headspace vials for laboratory use. Not intended for human or animal consumption, medical, diagnostic, therapeutic or veterinary use. These statements have not been evaluated by the FDA. The purchaser accepts full responsibility for safe handling, storage and lawful use.
Certificate of Analysis
Every batch is independently tested by a third-party laboratory for identity and purity. A Certificate of Analysis is available on request — contact us with your order or lot number and we'll send the COA for your specific batch.
Request a COAFor laboratory and research use only. Supplied in sterile, flip-top headspace vials for laboratory use. Not intended for human or animal consumption, medical, diagnostic, therapeutic or veterinary use. These statements have not been evaluated by the FDA. The purchaser accepts full responsibility for safe handling, storage and lawful use.